CME Information

LEARNING OBJECTIVES

Upon completion of the activity, participants should be able to:

• Use established diagnostic criteria to identify patients with COPD at an early stage of disease
• Modify the management of patients with COPD to reflect recent clinical results

FACULTY

James F. Donohue, MD
Professor of Medicine
Chief, Division of Pulmonary Diseases and Critical Care Medicine
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Donald P. Tashkin, MD
Distinguished Professor of Medicine
Division of Pulmonary and Critical Care Medicine
David Geffen School of Medicine
University of California at Los Angeles
Los Angeles, California

SPONSOR

This activity is sponsored by The France Foundation.

TARGET AUDIENCE

This educational activity is designed pulmonologists and other health care professionals who care for patients with COPD and who manage the complications related to this disease.

STATEMENT OF NEED

COPD is preventable and treatable but not usually reversible. Smoking cessation, reduction in lung hyperinflation through medical and surgical approaches, and long-term pharmacotherapy remain the three main approaches toward modifying the course of COPD. There are multiple guidelines that have been published and updated for the management of COPD. Primary care and pulmonary clinicians are most frequently the ones involved in the diagnosis and management of patients with COPD. In addition to the underdiagnosis of COPD, and despite the clinical guidelines, there are many patients that remain undertreated and/or inappropriately treated for their COPD.

ACCREDITATION STATEMENT

The France Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION

Physicians
The France Foundation designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses
Nurses who are certified by the American Nurses Credentialing Center (ANCC) may utilize activities that are certified by ACCME-accredited providers toward their requirement for certification renewal by the ANCC. A certificate of attendance will be provided by The France Foundation, an ACCME-accredited provider.

RESOLUTION OF CONFLICTS OF INTEREST

In accordance with the ACCME Standards for Commercial Support of CME, The France Foundation will implement mechanisms, prior to the planning and implementation of this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity.

DISCLOSURE

It is the policy of The France Foundation to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty, activity planners, content reviewers, and staff involved in the development of this activity have disclosed any significant financial interest or other relationship with manufacturer(s) of any commercial product(s)/device(s) and/or provider(s) of commercial services included in this educational activity. The intent of this disclosure is not to prevent a person with a relevant financial or other relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. The France Foundation has identified and resolved any and all conflicts of interest prior to the release of this activity.

Activity Staff Disclosures

The planners, reviewers, editors, staff, CME committee, or other members at The France Foundation who control content have no relevant financial relationships to disclose.

Faculty Disclosures

The following faculty have indicated they have relationships with industry to disclose relative to the content of this CME activity:

• Dr. Donohue has received grants/research support from Boehringer Ingelheim and GlaxoSmithKline. He has served as consultant for AstraZeneca, Boehringer Ingelheim, Forest, GlaxoSmithKline, Novartis, and Sepracor. Dr. Donohue has received honoraria from AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline.
• Dr. Tashkin has received grants/research support from AstraZeneca, Boehringer Ingelheim, Forest, GlaxoSmithKline, Novartis, Osiris, Pfizer, and Schering-Plough. He has served as consultant for AstraZeneca, Boehringer Ingelheim, Pfizer, and Schering-Plough. Dr. Tashkin has received honoraria from AstraZeneca, Boehringer Ingelheim, and Pfizer.

UNAPPROVED USE DISCLOSURE

The France Foundation requires CME faculty (speakers) to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.

COMMERCIAL SUPPORT ACKNOWLEDGMENT

This activity is supported by educational grant from AstraZeneca.

DISCLAIMER

The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and AstraZeneca assume no liability for the information herein.

COPYRIGHT INFORMATION

Copyright © 2010 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:

• The materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
• Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without The France Foundation's prior written permission.

PRIVACY POLICY

The France Foundation protects the privacy of personal and other information regarding participants and educational collaborators. The France Foundation will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME.

The France Foundation maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse or alteration of information that we have collected from you.

Additional information regarding The France Foundation's Privacy Policy can be viewed at http://www.francefoundation.com/privacy.

CONTACT INFORMATION

If you have questions about this CME activity, please contact The France Foundation at 860-434-1650 or info@francefoundation.com.